JP Morgan Chase
HLVX

JP Morgan Chase’s HilleVax HLVX Stock Holding History

JP Morgan Chase’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,598
Closed -$5.17K – 7547
2025
Q2 		$5.17K Sell
2,598
-45,418
-95% -$83.1K ﹤0.01% 6411
2025
Q1 		$69.6K Sell
48,016
-159,135
-77% -$294K ﹤0.01% 5748
2024
Q4 		$429K Buy
207,151
+193,124
+1,377% +$363K ﹤0.01% 5123
2024
Q3 		$24.7K Sell
14,027
-19,375
-58% -$49.7K ﹤0.01% 6191
2024
Q2 		$483K Sell
33,402
-13,670
-29% -$188K ﹤0.01% 4710
2024
Q1 		$783K Buy
47,072
+29,730
+171% +$476K ﹤0.01% 4513
2023
Q4 		$278K Sell
17,342
-4,606
-21% -$61.2K ﹤0.01% 5155
2023
Q3 		$295K Buy
21,948
+4,229
+24% +$59.5K ﹤0.01% 4798
2023
Q2 		$305K Buy
17,719
+2,810
+19% +$43.6K ﹤0.01% 4816
2023
Q1 		$246K Buy
14,909
+3,561
+31% +$57K ﹤0.01% 4938
2022
Q4 		$190K Buy
11,348
+4,266
+60% +$77K ﹤0.01% 5056
2022
Q3 		$121K Buy
7,082
+153
+2% +$2.23K ﹤0.01% 5199
2022
Q2 		$76K Buy
+6,929
New +$82.3K ﹤0.01% 5528

JP Morgan Chase's HLVX Position: Q3 2025 in Review

JP Morgan Chase sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 2,598 shares — an estimated $5.17K sold.

JP Morgan Chase first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $783K in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • JP Morgan Chase reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 2,598 HilleVax shares in Q3 2025, an estimated $5.17K.
  • JP Morgan Chase first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
  • JP Morgan Chase's HilleVax position peaked at $783K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.